Advertisement

International Urology and Nephrology

, Volume 51, Issue 4, pp 737–743 | Cite as

Ovarian reserve in an Egyptian cohort with end-stage kidney disease on hemodialysis and after successful kidney transplantation: a prospective study

  • Ahmed FayedEmail author
  • Ahmed Soliman
  • Mervat Naguib
  • Mahmoud Soliman
  • M. Salaheldin
Nephrology - Original Paper

Abstract

Background

Women with chronic kidney disease commonly have menstrual irregularities and fertility abnormalities. Antimüllerian hormone (AMH) and antral follicle count (AFC) are well-recognized indicators of ovarian reserve.

Aims

To assess AMH level and total AFC in women who are on hemodialysis and after successful kidney transplantation (KTx).

Methods

Sixty women with end-stage kidney disease (ESKD) on regular hemodialysis were included in this study with 20 patients of them were going to have renal transplant. Fifty age-matched healthy females were enrolled as control. Serum AMH level was measured in all participants once and in transplant patients four times (before surgery, and at 1, 6, and 12 months after surgery). AFC was evaluated once in all subjects and in transplant patients twice (before and 1 year after surgery).

Results

ESKD patients had significantly lower AMH concentration and AFC than healthy controls (1.8 ± 1.2 vs. 3.5 ± 1.7 ng/ml, p < 0.001) and (12 ± 4.6 vs. 17.4 ± 4.3, p < 0.001), respectively. In the subgroup transplant patients, AMH level decreased significantly from (1.7 ± 1.3 ng/ml) before Ktx to (1.5 ± 1.2 ng/ml, p = 0.001) at 1 month, (1.1 ± 0.9 ng/ml, p < 0.001) at 6 months, (0.9 ± 0.8 ng/ml, p < 0.001) at 1 year after Ktx. Also, total AFC declined in transplant females from (11.1 ± 4.5) before KTx to (6.6 ± 3.4) after KTx (p < 0.001).

Conclusions

Women with ESKD who are on hemodialysis have lower ovarian reserve than healthy females. Moreover, renal transplantation was associated with reduction in AMH level and AFC.

Keywords

Antimüllerian hormone Antral follicle count Chronic kidney disease 

Notes

Funding

This research did not receive any specific grant from any funding agency in the public, commercial, or not-for-profit sector.

Compliance with ethical standards

Conflict of interest

The authors have declared that no conflict of interest exists.

Ethical approval

The local ethical committee of the Internal Medicine department, School of Medicine, Cairo University, approved this work.

Research involving human and animal participants

All procedures performed in this study involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

References

  1. 1.
    Pietrzak B, Wielgos M, Kamiński P, Jabiry-Zieniewicz Z, Bobrowska K (2006) Menstrual cycle and sex hormone profile in kidney-transplanted women. Neuro Endocrinol Lett 27:198–202PubMedGoogle Scholar
  2. 2.
    Wang GC, Zheng JH, Xu LG et al (2010) Measurements of serum pituitary-gonadal hormones and investigation of sexual and reproductive functions in kidney transplant recipients. Int J Nephrol. 2010:612126CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Weisinger JR, Bellorin-Font E (2004) Outcomes associated with hypogonadismin women with chronic kidney disease. Adv Chronic Kidney Dis 11:361–370CrossRefPubMedGoogle Scholar
  4. 4.
    Holley JL, Schmidt RJ, Bender FH, Dumler F, Schiff M (1997) Gynecologic and reproductive issues in women on dialysis. Am J Kidney Dis 29:685–690CrossRefPubMedGoogle Scholar
  5. 5.
    Toma H, Tanabe K, Tokumoto T, Kobayashi C, Yagisawa T (1999) Pregnancy in women receiving renal dialysis or transplantation in Japan: a nationwide survey. Nephrol Dial Transpl 14:1511–1516CrossRefGoogle Scholar
  6. 6.
    Pietrzak B, Cyganek A, Jabiry-Zieniewicz Z et al (2006) Function of the ovaries in female kidney transplant recipients. Transpl Proc 38:180–183CrossRefGoogle Scholar
  7. 7.
    Sikora-Grabka E, Adamczak M, Kuczera P, Szotowska M, Madej P, Wiecek A (2016) Serum anti-müllerian hormone concentration in young women with chronic kidney disease on hemodialysis, and after successful kidney transplantation. Kidney Blood Press Res 41:552–560CrossRefPubMedGoogle Scholar
  8. 8.
    Younis JS (2012) Ovarian aging and implications for fertility female health. Minerva Endocrinol 37:41–57PubMedGoogle Scholar
  9. 9.
    Broekmans FJ, Kwee J, Hendriks DJ, Mol BW, Lambalk CB (2006) A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Update 12:685–718CrossRefPubMedGoogle Scholar
  10. 10.
    La Marca A, Stabile G, Artenisio AC, Volpe A (2006) Serum anti-Müllerian hormone throughout the human menstrual cycle. Hum Reprod 21:3103–3107CrossRefPubMedGoogle Scholar
  11. 11.
    Kalaiselvi VS, Saikumar P, Prabhu K, Prashanth Krishna G (2012) The anti mullerian hormone-a novel marker for assessing the ovarian reserve in women with regular menstrual cycles. J Clin Diagn Res 6:1636–1639PubMedPubMedCentralGoogle Scholar
  12. 12.
    Stoumpos S, Lees J, Welsh Pet al (2018) The utility of anti-Müllerian hormone in women with chronic kidney disease, on haemodialysis and after kidney transplantation. Reprod Biomed Online 36:219–226CrossRefPubMedGoogle Scholar
  13. 13.
    Shahrokhi SZ, Kazerouni F, Ghaffari F (2018) Anti-müllerian hormone: genetic and environmental effects. Clin Chim Acta 476:123–129CrossRefPubMedGoogle Scholar
  14. 14.
    Broekmans FJ, de Ziegler D, Howles CM, Gougeon A, Trew G, Olivennes F (2010) The antral follicle count: practical recommendations for better standardization. Fertil Steril 94:1044–1051CrossRefPubMedGoogle Scholar
  15. 15.
    Scheffer GJ, Broekmans FJ, Dorland M, Habbema JD, Looman CW, te Velde ER (1999) Antral follicle counts by transvaginal ultrasonography are related to age in women with proven natural fertility. Fertil Steril 72:845–851CrossRefPubMedGoogle Scholar
  16. 16.
    Lima ML, Martins WP, Coelho Neto MA, Nastri CO, Ferriani RA, Navarro PA(2015)The assessment of ovarian reserve by antral follicle count in ovaries with endometrioma. Ultrasound Obstet Gynecol 46: 239–242Google Scholar
  17. 17.
    Coelho Neto MA, Ludwin A, Borrell A et al (2018)) Counting ovarian antral follicles by ultrasound: a practical guide. Ultrasound Obstet Gynecol 51:10–20CrossRefPubMedGoogle Scholar
  18. 18.
    Ahmed SB, Ramesh S (2016) Sex hormones in women with kidney disease. Nephrol Dial Transplant 31:1787–1795CrossRefPubMedGoogle Scholar
  19. 19.
    Filocamo MT, Zanazzi M, Li Marzi V et al (2009) Sexual dysfunction in women during dialysis and after renal transplantation. J Sex Med 6:3125–3311CrossRefPubMedGoogle Scholar
  20. 20.
    Holley JL (2004) The hypothalamic-pituitary axis in men and women with chronic kidney disease. Adv Chronic Kidney Dis 11:337–341CrossRefPubMedGoogle Scholar
  21. 21.
    Anantharaman P, Schmidt RJ (2007) Sexual function in chronic kidney disease. Adv Chronic Kidney Dis 14:119–125CrossRefPubMedGoogle Scholar
  22. 22.
    Kristensen SL, Ramlau-Hansen CH, Andersen CY et al (2012) The association between circulating levels of antimüllerian hormone and follicle number, androgens, andmenstrual cycle characteristics in young women. Fertil Steril 97:779–785CrossRefPubMedGoogle Scholar
  23. 23.
    Hou S (1987) Pregnancy in women requiring dialysis for renal failure. Am J Kidney Dis 9:368–373CrossRefPubMedGoogle Scholar
  24. 24.
    Kuvacic I, Sprem M, Skrablin S, Kalafatic D, Bubic-Flipi L, Milici D (2000) Pregnancy outcome in renal transplant recipients. Int J Gynaecol Obstet 70:313–317CrossRefPubMedGoogle Scholar
  25. 25.
    Lessan-Pezeshki M, Ghazizadeh S, Khatami MR et al (2004) Fertility and contraceptive issues after kidney transplantation in women. Transplant Proc 36:1405–1406CrossRefPubMedGoogle Scholar
  26. 26.
    Rathi M, Ramachandran R (2012) Sexual and gonadal dysfunction in chronic kidney disease: pathophysiology. Indian J Endocrinol Metab 16:214–219CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Saha MT, Saha HH, Niskanen LK, Salmela KT, Pasternack AI (2002) Time course of serum prolactin and sex hormones following successful renal transplantation. Nephron 92:735–737CrossRefPubMedGoogle Scholar
  28. 28.
    Lawrenz B, Henes J, Henes M et al (2011) Impact of systemic lupus erythematosus on ovarian reserve in premenopausal women: evaluation by using anti-muellerian hormone. Lupus 20:1193–1197CrossRefPubMedGoogle Scholar
  29. 29.
    Livshits A, Seidman DS (2009) Fertility issues in women with diabetes. Womens Health (Lond) 5:701–707CrossRefGoogle Scholar
  30. 30.
    Leroy C, Rigot J-M, Leroy M et al (2015) Immunosuppressive drugs and fertility. Orphanet J Rare Dis 10:136CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Nature B.V. 2019

Authors and Affiliations

  1. 1.Nephrology Unit, Internal Medicine Department, School of MedicineCairo UniversityCairoEgypt
  2. 2.Endocrinology Unit, Internal Medicine Department, School of MedicineCairo UniversityCairoEgypt
  3. 3.Gynecology and Obstetrics DepartmentCairo University School of Medicine, Cairo UniversityCairoEgypt
  4. 4.Urology DepartmentCairo University School of Medicine, Cairo UniversityCairoEgypt

Personalised recommendations